Form 4: FactSet Director Laurie Siegel Receives Equity Grants

Sentiment:

Insider Transaction Report


FactSet Research Systems Inc. Director Laurie Siegel reported the acquisition of 626 common stock units and 1,531 stock options as compensation.

Summary

  • Laurie Siegel, a Director at FactSet Research Systems Inc. (FDS), acquired 626 shares of common stock on January 15, 2026, at a price of $0 per share.
  • These common stock units are restricted stock units that will cliff vest 100% on the first anniversary of the grant date.
  • Following this transaction, Siegel beneficially owns 1,663 shares of common stock directly.
  • Siegel also acquired 1,531 non-employee director stock options on January 15, 2026, with an exercise price of $289.68 per share.
  • These options will cliff vest 100% on January 15, 2027, and have an expiration date of January 15, 2033.
  • The options were granted at a price of $0 and represent the right to buy 1,531 shares of common stock.
  • Following this transaction, Siegel beneficially owns 1,531 derivative securities directly.

Sentiment

Score: 6

Explanation: The filing reports routine equity compensation for a non-employee director, aligning their interests with shareholders through restricted stock units and stock options. This is a standard corporate governance practice and generally viewed as a neutral to slightly positive event.

Positives

  • The grants of restricted stock units and stock options align the director's interests with those of shareholders, as the value of these awards is tied to the company's stock performance.
  • Equity compensation is a standard practice for non-employee directors, reflecting a commitment to long-term value creation.

Negatives

  • The reported transactions are grants of compensation rather than open market purchases, meaning there was no direct cash investment by the director at the time of acquisition.

Risks

  • The value of the restricted stock units and stock options is subject to market fluctuations of FactSet's common stock.
  • The options' value is dependent on the stock price exceeding the exercise price of $289.68.

Future Outlook

The filing indicates that the granted restricted stock units and stock options will vest on January 15, 2027, contingent on continued service as a director.

Industry Context

The granting of equity awards to non-employee directors is a common compensation practice across publicly traded companies, particularly in the financial information and technology sector, to align leadership incentives with shareholder returns.

Comparison to Industry Standards

  • The structure of these equity grants, including restricted stock units and stock options with a cliff vesting schedule, is consistent with typical non-employee director compensation packages observed in comparable companies within the financial data and analytics industry, such as S&P Global or MSCI.
  • The grant price of $0 for restricted stock units and options is standard for compensation awards, reflecting their nature as incentives rather than purchases.

Stakeholder Impact

  • Shareholders: The equity grants align the director's financial interests with long-term shareholder value creation.
  • Employees: No direct impact on employees is indicated by this filing.

Next Steps

  • The restricted stock units and stock options are scheduled to vest on January 15, 2027, subject to the director's continued service.

Key Dates

DateDescription
01/15/2026Date of grant for 626 restricted stock units and 1,531 non-employee director stock options.
01/15/2027Vesting date for both the 626 restricted stock units and the 1,531 non-employee director stock options (first anniversary of grant date).
01/20/2026Date the Form 4 was signed and filed.
01/15/2033Expiration date for the 1,531 non-employee director stock options.

Recommendation

hold

This Form 4 details routine equity compensation for a non-employee director, which is a standard practice to align director interests with shareholders. It does not provide new information that would alter the fundamental investment thesis for FactSet Research Systems Inc., hence a 'hold' recommendation is maintained based solely on this filing.

Keywords

FactSet, FDS, Laurie Siegel, Form 4, Insider Transaction, Stock Grant, Stock Option, Director Compensation, Equity Award

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.